Biobase China Nucleic Acid Extraction System for Medical

Name: Biobase China Nucleic Acid Extraction System for Medical
Brand: Biobase Biodustry (Shandong) Co., Ltd.
SKU: 757474572

Shandong, ChinaBiobase Biodustry (Shandong) Co., Ltd.

US$575.00-3,130.00

1 Piece

Sample price:US$4000.00/piece.Request sample

Product profile

Customization

Available

Classification

Biological Diagnostics

Type

Biochemistry Analyzer

Model NO.

BNP8

Certification

CE, ISO13485

Sample Quantity

Processing Volume

20-1000

Sample Volume

20-500

Sample Throughput

1-8

Magnetic Bead Recovery

>98%

Extracting The Difference Between Holes

CV<=3%

Reagent Type

Magnetic Bead Open Platform

Extraction Time

12-18 Min/Round (Depending on The Reagent Used)

Model Number

Bnp8

Power Supply

AC110/220V 10%

Dimension

385*370*395 mm

Weight

14.5 Kg

Transport Package

Cartoon Package or Other

Specification

BNP8

Trademark

BIOBASE

Origin

China

Production Capacity

1000 PCS Per Year

Company profile

Importers and ExportersYears of Export ExperienceExperienced TeamExhibition Experience

Biobase Biodustry (Shandong) Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 15 years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤3.75h

AI-Powered supplier vetting

SummaryThe supplier is identified as a combined company involved in medical-device sales, manufacturing, research and development, and related technical activities. It reports ISO9001:2015, ISO14001, and CE certifications, 100% finished-product inspection, five quality inspectors, and stated annual production capacities for Biological Safety Cabinets and Auto Chemistry Analyzers. R&D evidence includes new products in the past year, ODM services, and broad customization from samples, designs, or full specifications. Overseas support includes installation, repair, training, maintenance, and debugging, with overseas warehouses and agents or branches. Financial records are identified for 2022–2024, but no financial performance values are provided. Evidence of customer cases is limited to OEM service for popular brands and participation in the Pittcon Exhibition.

Supplier typeThe supplier is classified as a combined company. Its stated scope covers Class I, II, and III medical-device activities, including sales, production, research and development, medical services, and related installation or construction activities.

CertificationsThe supplier reports ISO9001:2015 and ISO14001 certifications, as well as CE product certification capability. The slices do not provide certificate validity dates or scope details, but they explicitly identify multiple certifications.

After-Sales capabilityThe supplier lists overseas installation, repair, training, maintenance, and debugging services, and reports overseas warehouses plus overseas agents or branches. It also has written service-capability procedures with follow-up records and 20 qualified service suppliers, although the stated overseas-service country count is zero.

R&D capabilityThe supplier reports new products during the past year, provides ODM services, and offers broad R&D customization. It does not have an available SDK, which limits evidence of software-development support but does not negate the documented product-development capability.

Production capacityThe supplier reports annual capacities of 10,000 Biological Safety Cabinets and 11,100 Auto Chemistry Analyzers, with laser cutting equipment and a bending machine. Its stated business scope also includes production of Class I, II, and III medical devices, while the adequacy of equipment and capacity for a specific order is not established.

Customization capabilityBoth R&D and design-capability records list customization from samples, customization from designs, full customization, minor customization, and flexible customization. This is explicit evidence of a broad customization offering.